Previous Close | 0.0737 |
Open | 0.0737 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0715 - 0.0807 |
52 Week Range | 0.0500 - 0.1500 |
Volume | |
Avg. Volume | 52,068 |
Market Cap | 8.829M |
Beta (5Y Monthly) | 1.45 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings Date | Nov 14, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for BUDZ
TUCSON, AZ / ACCESSWIRE / November 30, 2023 / WEED Inc. (OTCQB:BUDZ), ("WEED" or the "Company") a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment ...
WEED Inc. (OTCQB:BUDZ), ("WEED" or the "Company") a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases.
WEED Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), a global cannabis & hemp bioresearch company based in the USA focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases announced today that its wholly-owned subsidiary, HEMP Biosciences Inc., received its hemp cultivation license from the state of Arizona.